Vaxcyte Inc.

NASDAQ: PCVX · Real-Time Price · USD
32.66
1.23 (3.91%)
At close: Aug 15, 2025, 3:59 PM
32.70
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT

Vaxcyte Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 75M 9.2M 1.8M
Gross Profit
n/a -75M -9.2M -1.8M
Operating Income
-569.55M -468.04M -232.26M -103.67M
Interest Income
109.99M 62.91M 8.36M 344K
Pretax Income
-463.93M -402.27M -223.49M -100.08M
Net Income
-463.93M -402.27M -239.64M -100.08M
Selling & General & Admin
92.9M 60.7M 39.81M 25.26M
Research & Development
476.64M 332.34M 169.45M 78.41M
Other Expenses
n/a n/a -1.93M -1.58M
Operating Expenses
569.55M 468.04M 207.33M 102.08M
Interest Expense
n/a n/a 2K 7K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 468.04M 207.33M 102.08M
Income Tax Expense
n/a n/a 16.16M 7K
Shares Outstanding (Basic)
122M 97.16M 64.88M 51.92M
Shares Outstanding (Diluted)
122M 97.16M 64.88M 51.92M
EPS (Basic)
-3.8 -4.14 -3.69 -1.93
EPS (Diluted)
-3.8 -4.14 -3.69 -1.93
EBITDA
-448.08M -464.88M -214.29M -98.28M
EBIT
-463.93M -468.04M -223.49M -100.08M
Depreciation & Amortization
15.85M 3.16M 9.2M 1.8M